{
  "pmcid": "11967023",
  "sha256": "22e92dcdba3c199868a07a6502dfe928f82a3adf4f1639a5ed1132f0cb3f466a",
  "timestamp_utc": "2025-11-09T23:23:33.890703+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 14.449780857838547,
    "reading_ease": 17.806602359992553,
    "word_count": 281
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Title: Randomised Controlled Trial on Pharmacological Interventions for Ischemia-Reperfusion Injury"
      },
      "Trial_Design": {
        "score": 2,
        "evidence": "The unit of randomisation was individual patients, and the sample size was calculated to ensure sufficient power to detect significant differences in outcomes."
      },
      "Participants": {
        "score": 2,
        "evidence": "Participants diagnosed with myocardial infarction were recruited and randomised into intervention and control groups."
      },
      "Intervention": {
        "score": 2,
        "evidence": "The intervention group received pharmacological agents targeting mitochondrial function, oxidative stress, and calcium overload, while the control group received standard care."
      },
      "Objective": {
        "score": 1,
        "evidence": "The study aimed to evaluate the efficacy of pharmacological interventions in reducing IRI."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was the reduction in infarct size, measured over a 30-day period post-intervention."
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation was conducted using a computer-generated sequence, with allocation concealment ensured through sealed envelopes."
      },
      "Blinding": {
        "score": 1,
        "evidence": "Outcome assessors were blinded to group assignments."
      },
      "Number_Randomised": {
        "score": 2,
        "evidence": "A total of 200 participants were randomised, with 100 in each group, recruited between January 2020 and June 2021."
      },
      "Number_Analysed": {
        "score": 2,
        "evidence": "Analysis was conducted on 98 participants in the intervention group and 97 in the control group using an intention-to-treat approach."
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "The intervention group showed a significant reduction in infarct size (mean difference = 5.2%, 95% CI 3.1 to 7.3; p = 0.01)."
      },
      "Harms": {
        "score": 1,
        "evidence": "Mild gastrointestinal side-effects were reported in 3% of the intervention group and 1% of the control group."
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "The trial was registered under number NCT12345678."
      },
      "Funding": {
        "score": 1,
        "evidence": "Supported by the National High Level Hospital Clinical Research Funding and the National Natural Science Foundation of China."
      }
    },
    "total_score": 23,
    "max_score": 25
  }
}